⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MBRX News
Moleculin Biotech, Inc.
Moleculin to Present at 38th Annual ROTH Conference
globenewswire.com
MBRX
Moleculin to Present at 38th Annual ROTH Conference
globenewswire.com
MBRX
Global Anti-Scam Alliance Launches Scam.org with OpenAI and Key Partners
accessnewswire.com
MBRX
Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study
globenewswire.com
MBRX
Form 8-K
sec.gov
MBRX
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
globenewswire.com
MBRX
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
globenewswire.com
MBRX
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
globenewswire.com
MBRX
Moleculin Launches CEO Corner Platform to Share Strategic Insights
globenewswire.com
MBRX
JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026
accessnewswire.com
AKTX
DCOY
GRI
MBRX
AIM
BULL